JBMR Plus
Scope & Guideline
Fostering innovation in diabetes and orthopedic studies.
Introduction
Aims and Scopes
- Bone Biology and Physiology:
Research focusing on the fundamental biological processes of bone formation, remodeling, and metabolism, including studies on osteoblasts, osteoclasts, and osteocytes. - Bone Diseases and Disorders:
Investigations into various bone diseases such as osteoporosis, osteogenesis imperfecta, and hypophosphatasia, including their pathophysiology, clinical manifestations, and treatment options. - Clinical Trials and Interventions:
Reports on clinical trials assessing the efficacy and safety of pharmacological and non-pharmacological interventions for bone health, including bisphosphonates, parathyroid hormone analogs, and dietary supplements. - Imaging and Biomarkers:
Studies utilizing imaging techniques (e.g., HR-pQCT, DXA) and biomarkers to assess bone quality, density, and turnover, contributing to the understanding of fracture risk and treatment outcomes. - Genetic and Molecular Mechanisms:
Exploration of the genetic, epigenetic, and molecular pathways influencing bone health and disease, including the role of microRNAs, signaling pathways, and genetic variants. - Public Health and Epidemiology:
Research addressing public health aspects of bone health, including epidemiological studies on fracture incidence, risk factors, and the impact of lifestyle and environmental factors on bone health.
Trending and Emerging
- Microbiome and Bone Health:
Emerging studies highlight the relationship between gut microbiota and bone health, exploring how dietary components and microbiome alterations can affect bone metabolism. - Personalized Medicine in Osteoporosis:
There is an increasing focus on tailoring osteoporosis treatments based on genetic, phenotypic, and lifestyle factors, indicating a shift towards personalized approaches in managing bone diseases. - Digital Health and Osteoporosis Screening:
The integration of digital technologies and machine learning in osteoporosis risk assessment and screening is gaining traction, particularly in improving access and accuracy in clinical settings. - Inflammation and Bone Disease:
Research increasingly investigates the role of inflammatory processes in bone diseases, linking systemic inflammation to conditions like osteoporosis and osteoarthritis. - Nutritional Interventions:
A growing body of literature is examining the impact of specific dietary patterns, supplements, and functional foods on bone health, reflecting a trend towards preventive and integrative health strategies.
Declining or Waning
- Vitamin D Research:
While vitamin D is crucial for bone health, the volume of studies focusing solely on vitamin D supplementation and its direct effects on bone density has decreased, possibly due to previous extensive literature. - Traditional Osteoporosis Treatments:
Research on older treatments like estrogen replacement therapy and traditional bisphosphonates is declining, as newer therapies and combination approaches gain prominence. - Animal Models of Bone Disease:
There seems to be a reduction in studies using traditional animal models for bone disease, possibly shifting towards more clinically relevant human studies or advanced models. - Basic Science of Bone Mechanotransduction:
Research focused on the basic cellular mechanisms of how mechanical forces affect bone cells has seen less emphasis, as the field moves towards integrative approaches combining biomechanics and biology.
Similar Journals
Journal of Osteoporosis
Bridging Disciplines to Enhance Bone CareJournal of Osteoporosis is a leading open-access journal dedicated to the investigation and dissemination of research in the field of osteoporosis and related bone disorders. Published by HINDAWI LTD, the journal has been fostering academic discourse since 2010, ensuring that critical findings are accessible to researchers, clinicians, and policy-makers alike. With an ISSN of 2090-8059 and an E-ISSN of 2042-0064, it serves as a significant platform for advancing knowledge in Endocrinology, Diabetes, and Metabolism, currently holding Q4 and Q3 categorizations in respective quartiles as of 2023. The journal, which publishes annually and is based in the United States, plays a crucial role in documenting the evolving understanding of bone health, contributing to improved clinical practices and patient outcomes. As it converges insights from diverse fields, it is an essential resource for researchers aiming to impact the future of osteoporosis management and treatment.
EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES
Elevating Standards in Diabetes and Metabolic ResearchEXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES is a distinguished journal published by GEORG THIEME VERLAG KG, dedicated to advancing research and understanding in the fields of endocrinology, diabetes, and metabolism. With an ISSN of 0947-7349 and an E-ISSN of 1439-3646, this journal serves as a critical platform for disseminating high-quality research findings, reviews, and clinical studies from 1983 to 2024. The journal holds an impactful position within its respective categories, notably achieving Q3 in Endocrinology and Diabetes and Metabolism, and Q2 in Internal Medicine as per the 2023 category quartiles. Additionally, it ranks in the 57th and 46th percentiles in the Scopus rankings for Internal Medicine and Endocrinology, Diabetes and Metabolism, respectively. Though not an open-access publication, the journal caters to a global audience of researchers, professionals, and students, facilitating knowledge exchange and fostering collaboration within this vital area of medical science.
Annals of Pediatric Endocrinology & Metabolism
Advancing knowledge in pediatric endocrinology and metabolism.Annals of Pediatric Endocrinology & Metabolism, published by the Korean Society of Pediatric Endocrinology, is a vital resource for researchers, healthcare professionals, and students in the fields of endocrinology, diabetes, and pediatric health. With its commitment to open access since 2012, the journal facilitates the dissemination of groundbreaking research on pediatric endocrine disorders and metabolic diseases, ensuring that vital knowledge is accessible to a global audience. The journal maintains a reputable standing with a 2023 Scopus rank of #92 in Pediatrics and a Q3 quartile in Endocrinology, highlighting its impact on the field. Originating from South Korea, the journal fosters a collaborative network of researchers and advocates best practices in pediatric care through interdisciplinary studies. The Annals not only enhances scientific understanding but also emphasizes practical applications aimed at improving child health outcomes, making it an essential publication for academics and practitioners alike.
JOURNAL OF BONE AND MINERAL METABOLISM
Transforming the landscape of bone and mineral research.JOURNAL OF BONE AND MINERAL METABOLISM, published by SPRINGER JAPAN KK, is a leading peer-reviewed journal dedicated to advancing the field of bone and mineral research since its establishment in 1988. With ISSN 0914-8779 and E-ISSN 1435-5604, this esteemed journal offers a platform for high-quality research that intersects Endocrinology, Diabetes and Metabolism, Orthopedics and Sports Medicine, and related disciplines. Recognized for its rigorous standards, it holds a commendable Q2 ranking in multiple categories, reflecting its broad influence and relevance in contemporary medical research. Researchers and practitioners alike benefit from its evidence-based articles and insights, which contribute significantly to our understanding of metabolic bone diseases and mineral homeostasis. Although not an open-access journal, it still provides essential information and advancements crucial for professionals and scholars dedicated to improving clinical outcomes and enhancing patient care in these vital areas. To learn more, please explore the journal's archives and latest publications.
Journal of Clinical and Translational Endocrinology
Empowering Knowledge in Clinical and Translational Endocrinology.Journal of Clinical and Translational Endocrinology is a peer-reviewed open access journal published by Elsevier that has been serving the endocrinology community since its inception in 2014. With an ISSN of 2214-6237, this journal focuses on the critical intersection of clinical and translational research in endocrinology, diabetes, and metabolism, offering insights that bridge laboratory discoveries with patient care. It holds a commendable position in the field, ranking Q3 for Endocrinology and Q2 for Endocrinology, Diabetes, and Metabolism, reflecting its rigorous standards and relevance to contemporary research. Situated in the Netherlands, the journal’s aim is to foster knowledge dissemination and collaboration among professionals, researchers, and students alike, ensuring high visibility in a rapidly evolving field. The journal is committed to open access, allowing immediate access to research findings, thus maximizing their impact and facilitating advancements in clinical practice and research. With an H index that showcases its contribution to the field, Journal of Clinical and Translational Endocrinology is an essential resource for anyone invested in advancing endocrinological science.
Journal of Hard Tissue Biology
Connecting Researchers in the Realm of Hard TissuesJournal of Hard Tissue Biology, published by JOURNAL HARD TISSUE BIOLOGY, is a pivotal resource for researchers and practitioners engaged in the multifaceted fields of biochemistry, biomaterials, cell biology, dentistry, and orthopedics. With an ISSN of 1341-7649 and a publication history spanning from 2003 to 2024, this journal aims to disseminate innovative findings and review articles that contribute to the understanding of hard tissue structures and their applications in medicine. Despite its current Q4 ranking across several categories, including Biochemistry and Oral Medicine, the journal serves as a critical platform for emerging research, appealing to those dedicated to advancing the science of hard tissues. While it operates under a subscription model, the articles published here are essential for anyone seeking comprehensive insights into the biological, mechanical, and clinical aspects of hard tissues. The journal's commitment to excellence and its ongoing contributions make it an indispensable tool for students, researchers, and professionals aiming to enhance their understanding of hard tissue biology.
Bone Reports
Bridging research and practice for enhanced bone health.Bone Reports is a premier, peer-reviewed journal published by Elsevier that has been committed to advancing the field of orthopedics, sports medicine, and endocrinology since its inception as an open-access journal in 2015. With an ISSN of 2352-1872, this esteemed publication seeks to disseminate high-quality research that spans a diverse array of topics related to bone health, metabolic diseases, and musculoskeletal disorders. The journal boasts an impressive impact factor, contributing significantly to its recognition, with a Q2 ranking in Orthopedics and Sports Medicine and a Q3 ranking in Endocrinology, Diabetes, and Metabolism as of 2023. This open-access model enhances accessibility and engagement, allowing researchers, professionals, and students alike to stay at the forefront of developments in these critical areas. With an emphasis on rigorous methodology and innovative findings, Bone Reports is poised to become a vital resource for anyone interested in the latest advances in bone research and clinical applications.
Archives of Endocrinology Metabolism
Advancing knowledge in endocrinology and metabolism.Archives of Endocrinology Metabolism is a distinguished open-access journal dedicated to advancing the field of endocrinology and metabolism. Published by SBEM-SOC BRASIL ENDOCRINOLOGIA & METABOLOGIA, this journal has established itself as a vital platform for researchers, clinicians, and scholars since its inception in 2008. With an ISSN of 2359-3997 and E-ISSN of 2359-4292, it aims to disseminate high-quality research articles that explore the latest advancements in endocrinology, diabetes, and metabolism. As of 2023, it has achieved a commendable Q3 ranking in its field, demonstrating its relevancy and increasing visibility among peers. The journal's focus spans various sub-disciplines, including hormonal regulation, metabolic disorders, and innovative therapies, making it an essential resource for both emerging professionals and seasoned experts alike. With a rich repository of research from Brazil and beyond, Archives of Endocrinology Metabolism continuously seeks to contribute to the ongoing dialogue and collaboration within the global scientific community.
International Journal of Endocrinology
Connecting research and practice for better health outcomes.The International Journal of Endocrinology is a premier peer-reviewed journal, published by HINDAWI LTD, focusing on the rapidly evolving fields of endocrinology, diabetes, and metabolism. Since its establishment in 2009, the journal has embraced an Open Access model, ensuring that cutting-edge research is accessible to a global audience without barriers. With an impressive Scopus rank placing it within the top quartiles of related fields, it ranks #103 in Endocrinology, Diabetes and Metabolism, showcasing its significant contribution to the ongoing discourse in these areas. The journal's scope includes original research, reviews, and clinical studies that advance understanding and treatment strategies for endocrine disorders. By bridging the gap between research, clinical practice, and patient care, the International Journal of Endocrinology serves as an essential resource for researchers, practitioners, and students dedicated to the field of endocrinology. Addressed from its headquarters in the United States, this journal not only contributes to academic advancement but also fosters international collaboration in addressing key challenges in endocrinology.
Diabetes Epidemiology and Management
Driving Change through Open Access ResearchDiabetes Epidemiology and Management, published by Elsevier, is an innovative open-access journal that has been addressing the critical issues surrounding diabetes since its inception in 2021. This journal integrates a comprehensive exploration of the epidemiology, prevention, and management of diabetes, making it a pivotal resource within the fields of Endocrinology, Diabetes and Metabolism, and Internal Medicine. With a digital presence represented by E-ISSN 2666-9706, it currently holds a commendable position in the academic landscape, categorized in the Q3 quartile for both Endocrinology and Internal Medicine as per the 2023 metrics. The journal aims to enhance understanding and promote research on diabetes, offering authors a platform to share their findings with a global audience. Researchers, professionals, and students alike can benefit from this essential resource, which is dedicated to advancing the knowledge base and improving clinical practices in diabetes management. With open access options since 2021, the journal ensures that vital research is widely accessible, driving innovation and collaboration in the fight against diabetes.